Literature DB >> 6379946

Macular edema. A complication of diabetic retinopathy.

F L Ferris, A Patz.   

Abstract

Diabetic macular edema is the leading cause of decreased vision from diabetic retinopathy. This decreased vision is caused by an increase in extracellular fluid within the retina distorting the retinal architecture and frequently taking on a pattern of cystoid macular edema. This fluid accumulates within the retina because of the breakdown of the barriers within the retinal blood vessels and possibly the pigment epithelium. Diabetic macular edema tends to be a chronic disorder. Although spontaneous recovery is not an uncommon occurrence, over one-half of diabetics with macular edema will lose two or more lines of visual acuity within two years. The most promising treatment for diabetic macular edema has been photocoagulation. It is recommended that in all patients with diabetic macular edema attempts be made to normalize elevated blood glucose, decrease elevated blood pressure, and improve cardiac or renal status. Reduction of serum lipids by diet or pharmacologic means is an unproven treatment at this time. The Early Treatment Diabetic Retinopathy Study hopefully will provide more definitive information as to whether photocoagulation is effective in various subgroups of patients with diabetic macular edema.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6379946     DOI: 10.1016/0039-6257(84)90227-3

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  72 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Conditioned medium from mixed retinal pigmented epithelium and Müller cell cultures reduces in vitro permeability of retinal vascular endothelial cells.

Authors:  M Tretiach; M C Madigan; M C Gillies
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

3.  Characterization of a mouse model of hyperglycemia and retinal neovascularization.

Authors:  Elizabeth P Rakoczy; Ireni S Ali Rahman; Nicolette Binz; Cai-Rui Li; Nermina N Vagaja; Marisa de Pinho; Chooi-May Lai
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

4.  Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser.

Authors:  Y Oshima; K Emi; S Yamanishi; M Motokura
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

5.  Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.

Authors:  Figen Batioğlu; Emin Ozmert; Neslihan Parmak; Selcen Celik
Journal:  Int Ophthalmol       Date:  2007-04-24       Impact factor: 2.031

6.  A severity scale for diabetic macular edema developed from ETDRS data.

Authors:  Ronald E Gangnon; Matthew D Davis; Larry D Hubbard; Lloyd M Aiello; Emily Y Chew; Frederick L Ferris; Marian R Fisher
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

7.  Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment.

Authors:  Ashay D Bhatwadekar; Viral S Kansara; Thomas A Ciulla
Journal:  Expert Opin Investig Drugs       Date:  2020-01-31       Impact factor: 6.206

8.  Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema.

Authors:  C Hudson; J G Flanagan; G S Turner; H C Chen; L B Young; D McLeod
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

9.  Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation.

Authors:  Neil M Bressler; Allison R Edwards; Roy W Beck; Christina J Flaxel; Adam R Glassman; Michael S Ip; Craig Kollman; Baruch D Kuppermann; Thomas W Stone
Journal:  Arch Ophthalmol       Date:  2009-12

10.  Non-retinovascular leakage in diabetic maculopathy.

Authors:  D Weinberger; S Fink-Cohen; D D Gaton; E Priel; Y Yassur
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.